Navigation Links
AspenBio Announces Dismissal of Class Action and Chipman Lawsuits by U. S. District Court
Date:9/18/2012

CASTLE ROCK, Colo., Sept. 18, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that the United States District Court for Colorado has dismissed and entered judgment without prejudice in both the class action lawsuit (Case No. 11-cv-00165-REB-KMT) against the company and certain of its former or current officers and directors, and the Mark Chipman lawsuit (Case No. 11-cv-00163-REB-KMT) against the company.

"We are very pleased with the court's decisions," stated Steve Lundy, President and CEO of AspenBio.  "We continue to execute on our priority of advancing AppyScore™ toward commercialization."

About AspenBio Pharma
AspenBio Pharma, Inc. is an in vitro diagnostic company focused on the clinical development and commercialization of its lead product, AppyScoreAppyScore is a unique blood-based test with projected high sensitivity and negative predictive value that is designed to aid in the identification of patients at low risk for acute appendicitis, allowing for more conservative patient management.  AppyScore is initially being developed for pediatric, adolescent and young adult patients with abdominal pain as this population is at the highest risk for appendicitis as well having the highest risk of the long-term health effects associated with CT imaging.  For more information, visit www.aspenbiopharma.com.

Forward-Looking Statements
This press release includes "forward-looking statements" of AspenBio Pharma, Inc. ("AspenBio") as defined by the Securities and Exchange Commission ("SEC"). All statements, other than statements of historical fact, included in this press release that address activities, events or developments that AspenBio believes or anticipates will or may occur
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Neogen Corporation Announces 1st Quarter Results Conference Call
2. Genomic Health Announces Positive Topline Results of Large Prostate Cancer Clinical Validation Study; Company to Proceed with 2013 Commercial Launch
3. Kymab Announces Launch of Kymouse HK
4. AMRI Announces Strategic Contract with Knopp Biosciences
5. Ceramic Society announces selection of Ichinose, Lawn and Moskowitz as 2012 Distinguish Life Members
6. Islet Sciences Announces Exclusive License Agreement with the University of California (UCLA) to Commercialize Small Molecules for Islet Expansion
7. Sequenom Announces Participation At Two Upcoming Investor Conferences
8. BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference
9. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
10. Pro Bono Bio Announces the Successful Development of Subcutaneous and Long-Acting Blood Factors VIIa,VIII and IX for the Treatment of Haemophilia
11. Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... MILFORD, Mass., May 11, 2011 SeraCare Life Sciences, ... sciences company providing vital products and services to facilitate ... therapeutics, today announced the election of Joseph Nemmers and ... announced that Mr. Nemmers has been appointed to the ...
... Reportlinker.com announces that a new market research ... Healthcare Information Technology ... HIGHLIGHTS * BCC estimates the ... covered in this report at more than $6.3 ...
... DIEGO, May 11, 2011 OncoSec Medical Inc. ... medical approaches to treat solid tumor cancers that ... of three members to its leadership team. Formed ... II clinical trials for its tumor-destroying, tissue-sparing ElectroOncology ...
Cached Biology Technology:SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 2SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 3SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 4Reportlinker Adds Healthcare Information Technology 2Reportlinker Adds Healthcare Information Technology 3Reportlinker Adds Healthcare Information Technology 4Reportlinker Adds Healthcare Information Technology 5Reportlinker Adds Healthcare Information Technology 6Reportlinker Adds Healthcare Information Technology 7Reportlinker Adds Healthcare Information Technology 8Reportlinker Adds Healthcare Information Technology 9Reportlinker Adds Healthcare Information Technology 10Reportlinker Adds Healthcare Information Technology 11OncoSec Announces Leadership Team Appointments 2OncoSec Announces Leadership Team Appointments 3OncoSec Announces Leadership Team Appointments 4
(Date:12/17/2014)... FORT BELVOIR, Va. , Dec. 15, 2014 ... its efforts to make it easier to detect ... supply chain. Today the agency started ... marking. The capability will validate the authenticity of ... supply chain. The new quality control measures will ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... /PRNewswire/ -- SailPoint today ... Software that allows BMC to directly distribute ... been tightly integrated with BMC,s Business Service Management ... to the industry,s leading identity GRC solution, helping ...
... studying human reproduction have identified what is likely ... increase in aneuploidy, the term for an abnormal ... Using naturally aging mouse models, researchers showed that ... likely caused by weakened chromosome cohesion. Older ...
... the scientific journal , Osteoporosis International , introduces a ... the current and future burden of postmenopausal osteoporosis in ... researchers from the UK on behalf of the International ... validated using Swedish data. It can be used to ...
Cached Biology News:SailPoint Signs International Reseller Agreement with BMC Software 2SailPoint Signs International Reseller Agreement with BMC Software 3Why the biological clock? Penn study says aging reduces centromere cohesion, disrupts reproduction 2
... utility and flexibility press-to-seal silicone isolators can ... the researcher. They are available either pre-cut ... material that can be easily trimmed to ... and non-cytotoxic and can be used to ...
Request Info...
... turntable. Provides up to 30 minutes of walkaway time. Automatic Calibration. Five minute ... RS-232 port. ... ... ...
... • Holds 0.1 mL - 25 mL pipets ... pipets. Also accommodates most standard square or round pipet ... Has four compartments, each 76 mm W x 76 ... x 11 3/8 ins.). Overall dimensions: 89 mm W ...
Biology Products: